3645 results for «464»

Filter By

3645 results

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

M-TEER for challenging anatomy

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...

M-TEER for challenging anatomy

TAVI burning issues

09 Feb 2025 – From PCR Tokyo Valves 2025

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

TAVI burning issues

Imaging in TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...

Imaging in TAVI

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?